Updated: May 23, 2021 9:39:14 pm
The Serum Institute has disassociated itself from its executive director’s statement that the government began the COVID-19 vaccination of multiple age groups without taking into consideration the available stock, stating that this is “not the view of the company”.
In a letter to the Union Health Ministry on May 22, Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Pune-based Serum Institute of India (SII), clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company, sources said.
He isn’t authorized to speak on these issues only the official spokesperson of the company is allowed to speak: Serum Institute of India CEO Adar Poonawalla to ANI on company's Executive Director Sudesh Jadhav’s statement over vaccine stock pic.twitter.com/vOKKrMUuUc
— ANI (@ANI) May 23, 2021
“On behalf of our CEO Adar C Poonawalla, I want to inform you that this statement is not issued on behalf of SIIPL (Serum Institute of India Private Limited) and the Company completely dissociates itself from this statement. It is reiterated that, this is not the view of the company at all.
“SIIPL is committed to maximise its Covishield production and it stands shoulder to shoulder to strengthen the government’s fight against COVID-19,” he said in a communique.
SII also clarified that Poonawalla is the only official spokesperson of the company.
Amid an acute shortage of COVID-19 vaccines in the country, SII executive director Suresh Jadhav on Friday alleged that the government began inoculating people from multiple age groups without taking into account the available stock of vaccines and the WHO guidelines.
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines
- The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.